Connect Biopharma (CNTB) - Earnings growth in current year
How can profitability be ensured in the chronic immune pathology therapy segment lacking effective treatment? The relative EPS YoY trend reflects profit dynamics, where the current level stands at approximately 1.20. Stability is guaranteed by management's pragmatic expense control and transparent reporting. Growth prospects rely on the patent protection of molecules and the transition of the small molecule pipeline to the solution validation stage for Connect Biopharma (CNTB).
Analytical breakdowns and data insights for company connectbiopharm.com (CNTB)
- price and consensus price forecast:
- market capitalization indicators:
- book capitalization data:
- debt and liquidity details:
Total Debt to Equity Ratio Connect Biopharma|CNTB - Long-Term Debt to Equity|Current Liabilities to Capital Connect Biopharma Holdings Limited|CNTB - Company Debts|Debt to Book Value Ratio CNTB|CNTB - Company Long-Term Debt|Company Short-Term Indebtedness Connect Biopharma|Immediate Liquidity connectbiopharm.com
- earnings and market ratios statistics:
CNTB - Net Profit|Future Profit Connect Biopharma|CNTB - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Connect Biopharma Holdings Limited|CNTB - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation CNTB|CNTB - Operating profit EBITDA|Earnings per share for the last twelve months Connect Biopharma|CNTB - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months connectbiopharm.com|CNTB - Earnings per share growth in current year|Expected net earnings per share growth next year Connect Biopharma
Basic company analysis:Connect Pharma
For Connect Biopharma (CNTB), the annual EPS trend reflects business efficiency amid the regulatory standoff between the US and China. This metric measures the rate of change in net profit per share relative to the same period last year. The calculation is based on the percentage difference between current and historical EPS values. Growth in this metric confirms the model's resilience to geopolitical risks. Investors should view this indicator as a marker of the startup's operational viability.
Main competitors
Net earnings per share growth this year argenx N.V.|Net earnings per share growth this year BNTX|Earnings growth in current year abivax.com|Earnings per share growth in current year ADMA Biologics (ADMA)|protagonist-inc.com - Earnings per share growth this year|Earnings growth in current year IMVT (Immunovant)|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Earnings per share growth rate in current year|Grifols Group - Earnings growth in current year|Adaptive Biotechnologies Inc. (ADPT) - Net earnings per share growth this year|Celldex Therapeutics (CLDX) - Earnings per share growth in current year|Earnings per share growth rate in current year auriniapharma.com (AUPH)|Earnings per share growth in current year BioCryst Pharmaceuticals|Earnings per share growth this year VERA (Vera Therapeutics Inc)|Earnings per share growth in current year Dianthus Pharma (DNTH)|Pharvaris Pharma - Earnings per share growth this year|Earnings growth in current year ABCL (AbCellera Biologics)|tourmalinebio.com (TRML) - Earnings per share growth rate in current year|Precigen - Earnings growth in current year|Pharming Group NV (PHAR) - Net earnings per share growth this year|NKTR (Nektar) - Net earnings per share growth this year|UPB: Net earnings per one share growth for the current year|Net earnings per share growth this year ZBIO|IMNM: Earnings per share increase in current year|Earnings growth in current year GOSS|Earnings per share growth in current year KALV (KalVista Pharma)|Earnings growth in current year SEPN (Septerna Corp)|Expected net earnings per share growth this year Pieris Corp (PVLA)|SVRA - Earnings per share growth in current year|Earnings per share growth rate in current year rigel.com|AnaptysBio (ANAB) - Earnings per share growth in current year|Earnings per share trend in current year ATXS (Astria Therapeutics Inc)|ENGN (enGene Bio) - Earnings growth in current year|RAPT: Earnings per share increase in current year|Earnings growth in current year JBIO|Earnings growth in current year aclaristx.com (ACRS)|Earnings per share growth in current year Kyverna Therapeutics, Inc. KYTX|Earnings per share increase in current year TLSA|CABA - Earnings per share growth in current year|Ventyx Biosciences, Inc (VTYX) - Net earnings per share growth this year|THTX: Earnings growth in current year|avalotx.com (AVTX) - Earnings growth in current year|ELDN (Eledon Pharmaceuticals, Inc.) - Earnings growth in current year|Net earnings per share growth this year Agenus, Inc. (AGEN)|Earnings per share growth in current year Climb Bio, Inc. (CLYM)|Zura Bio Ltd - Earnings per share growth this year|aTyr Pharma, Inc. - Net earnings per share growth this year|Net earnings per one share growth for the current year ADAG (Adagene Inc)|Ikena Oncology, Inc. - Earnings growth in current year|STTK: Earnings per share growth in current year|equilliumbio.com (EQ) - Earnings per share growth in current year|Earnings per share trend in current year IMUX (Immunic)|ATRA (Atara Biotherapeutics, Inc.) - Earnings growth in current year|IFRX: Earnings per share increase in current year|Earnings growth in current year XFOR|Earnings growth in current year adicetbio.com (ACET)|Earnings per share growth in current year Celularity CELU|Earnings per share increase in current year INMB|BRNS - Earnings per share growth in current year|kezarlifesciences.com (KZR) - Net earnings per share growth this year|SABS: Earnings growth in current year|Akari Therapeutics PLC (AKTX) - Earnings growth in current year|Net earnings per share growth this year ENLV|QTTB: Earnings per share increase in current year|Earnings growth in current year GOVX|Expected net earnings per share growth this year edesabiotech.com|Earnings per share growth in current year iBio IBIO|CARM - Net earnings per share growth this year|XTLB - Earnings per share growth in current year|Bolt Biotherapeutics (BOLT) - Net earnings per share growth this year|HCWB (hcwbiologics.com) - Net earnings per share growth this year|Aptevo Therapeutics Inc. (APVO) - Earnings growth in current year|Earnings per share growth in current year AIM ImmunoTech Inc.|Earnings per share growth this year ADTX (Aditxt Corp)|Earnings growth in current year GRI|XRTX - Earnings per share growth rate in current year|Earnings growth in current year HIND (Vyome Holdings Inc)|REVB - Net earnings per share growth this year|INDP - Earnings per share growth in current year|Earnings per share growth rate in current year Scinai Immunotherapeutics Ltd|calcimedica.com (CALI) - Earnings per share growth in current year|Earnings per share growth this year AFMD|Earnings per share growth in current year Allakos Inc|Earnings per share growth this year HOOK (HOOKIPA)|Earnings growth in current year IGMS|ITOS - Earnings per share growth rate in current year|Earnings growth in current year OCEA (Ocean Bio)|TCBP - Net earnings per share growth this year|THRD: Net earnings per share growth this year
